Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in March.
TD Cowen’s 44th Annual Health Care Conference
Date: Tuesday, March 5, 2024
Formal Presentation: 2:50 p.m. ET
Location: Boston, MA
Barclays 26th Annual Global Healthcare Conference
Date: Thursday, March 14, 2024
Fireside Chat: 11:45 p.m. ET
Live webcasts of the TD Cowen presentation and Barclays fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Direct: (317) 767-4764
Investor and Media Contact:
Stern Investor Relations